OBJECTIVE. Precision medicine in oncology aims to individualize the patient's treatment and management regimen according to the accurate assessment of diagnosis, risk of recurrence, or progression. In this review, we will discuss the evolving role of molecular imaging (breast-specific gamma imaging and positron emission mammography) toward precision medicine in patients with breast cancer. CONCLUSION. Incorporating molecular imaging for breast cancer will lead to precision medicine, which holds promise to facilitate appropriate personalized treatment in patients with breast cancer.
Keywords: FDG; MRI; PEM; PET/CT; breast MRI; breast cancer; gamma-specific breast imaging; mammography; molecular breast imaging; precision medicine; scintimammography.